GLDMDG
Great Lakes Drug Metabolism and Disposition Group

About Us

About the GLDMDG

 

About Us

poster_1.jpg

Our Purpose

The purpose of the Great Lakes Drug Metabolism and Disposition Group (GLDMDG) is to facilitate interactions among scientists interested in all aspects of drug metabolism and disposition. Since 2006, the GLDMDG organizes meetings to promote the collegial exchange of ideas on current topics of interest to its members.

We believe the potential benefits of this organization includes:

  • Providing opportunities for graduate students, postdoctoral fellows and senior level associates from regional universities to meet pharmaceutical scientists and pharmacologists from various academic and industrial backgrounds.

  • Promoting regional visibility of the discipline of drug metabolism and disposition science.

  • Facilitating informal dialogue between pharmaceutical partners and academic laboratories to discuss current challenges and emerging opportunities.

  • Enriching interdisciplinary collaboration opportunities for those interested in drug metabolism and disposition.

Steering Committee

  • Dan Albaugh, Labcorp Drug Development

  • Wendy Collard, Zoetis

  • Leslie Dickmann, University of Wisconsin - Madison

  • Shuiying Hu, The Ohio State University

  • Gary Jenkins, AbbVie

  • Young Jeong, Purdue University

  • Anthony Lee, Pfizer

  • Michael Mohutsky, Lilly

  • Yoichi Osawa, University of Michigan

  • Manish Sharma, Charles River Laboratories

  • Stephen Sligar, University of Illinois at Urbana-Champaign

  • Richard Voorman, RMLV

  • Joe Ware, GLDMDG Volunteer